Skip to main content
. 2022 Jun 7;19(6):e1003998. doi: 10.1371/journal.pmed.1003998

Fig 3. OS in patients in the low-burden metastatic disease group.

Fig 3

Adjusted HR = 0.64 (95% CI 0.52 to 0.79; p < 0.001 [p = 0.00004]). HR, hazard ratio; OS, overall survival; RT, radiotherapy to the prostate; SOC, standard of care.